Kaico Ltd.

Japan

Back to Profile

1-16 of 16 for Kaico Ltd. Sort by
Query
Aggregations
IP Type
        Trademark 8
        Patent 8
Jurisdiction
        World 7
        Canada 5
        United States 4
Date
2026 July 1
2026 (YTD) 1
2025 2
2024 4
2023 6
See more
IPC Class
A61P 37/04 - Immunostimulants 7
A61K 39/00 - Medicinal preparations containing antigens or antibodies 6
C12N 15/866 - Baculoviral vectors 5
A61K 35/64 - Insects, e.g. bees, wasps or fleas 4
A61K 39/12 - Viral antigens 4
See more
NICE Class
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations 8
05 - Pharmaceutical, veterinary and sanitary products 8
42 - Scientific, technological and industrial services, research and design 5
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 5
Status
Pending 6
Registered / In Force 10

1.

ORAL VACCINE COMPOSITION AGAINST FELINE VIRAL INFECTION VIRUS

      
Application Number JP2025035727
Publication Number 2026/140419
Status In Force
Filing Date 2025-10-08
Publication Date 2026-07-02
Owner KAICO LTD. (Japan)
Inventor
  • Yamato, Kenta
  • Taniguchi, Masahiro
  • Fujikawa, Takumi
  • Esaki, Keiichi

Abstract

This oral vaccine composition against feline viral infection virus comprises pupae or cells of a baculovirus-infectable insect that has been: infected with recombinant baculovirus into which DNA that encodes viral proteins causing feline viral infections has been introduced; and dried.

IPC Classes  ?

  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
  • A23K 50/40 - Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
  • A61K 35/64 - Insects, e.g. bees, wasps or fleas
  • A61K 39/23 - Parvoviridae, e.g. feline panleukopenia virus
  • A61P 31/20 - Antivirals for DNA viruses
  • A61P 37/04 - Immunostimulants
  • C12N 5/10 - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells
  • C12N 7/01 - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material
  • C12N 15/35 - Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
  • C12N 15/866 - Baculoviral vectors
  • C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

2.

ORAL VACCINE COMPOSITION

      
Application Number 18870285
Status Pending
Filing Date 2023-06-02
First Publication Date 2025-10-23
Owner
  • KAICO LTD. (Japan)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japan)
Inventor
  • Yamato, Kenta
  • Taniguchi, Masahiro
  • Nakatake, Hirokazu
  • Esaki, Keiichi
  • Kusakabe, Takahiro

Abstract

An oral vaccine composition against porcine circovirus associated diseases, comprising the pupa or cell of a baculovirus infectious insect, which is subjected to an infection treatment with a recombinant baculovirus, into which porcine circovirus type 2 protein-encoding DNA is introduced, and a freeze-drying treatment.

IPC Classes  ?

3.

ORAL VACCINE COMPOSITION

      
Document Number 03257931
Status Pending
Filing Date 2023-06-02
Open to Public Date 2025-04-09
Owner
  • KAICO LTD. (Japan)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japan)
Inventor
  • Yamato, Kenta
  • Taniguchi, Masahiro
  • Nakatake, Hirokazu
  • Esaki, Keiichi
  • Kusakabe, Takahiro

Abstract

An oral vaccine composition against porcine circovirus associated diseases, comprising the pupa or cell of a baculovirus infectious insect, which is subjected to an infection treatment with a recombinant baculovirus, into which porcine circovirus type 2 protein-encoding DNA is introduced, and a freeze-drying treatment.

IPC Classes  ?

  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • A61K 35/64 - Insects, e.g. bees, wasps or fleas
  • A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • A61P 11/00 - Drugs for disorders of the respiratory system
  • A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
  • A61P 17/00 - Drugs for dermatological disorders
  • A61P 31/20 - Antivirals for DNA viruses
  • A61P 37/04 - Immunostimulants
  • C12N 7/01 - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material
  • C12N 15/34 - Proteins from DNA viruses
  • C12N 15/86 - Viral vectors
  • C12N 15/866 - Baculoviral vectors

4.

ORAL VACCINE COMPOSITION

      
Application Number 18285970
Status Pending
Filing Date 2022-04-08
First Publication Date 2024-06-06
Owner
  • KAICO LTD. (Japan)
  • KAGOSHIMA UNIVERSITY (Japan)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japan)
Inventor
  • Yamato, Kenta
  • Miyata, Takeshi
  • Kusakabe, Takahiro
  • Lee, Jae Man
  • Masuda, Akitsu

Abstract

A method of easily producing an immunogenic pupa for oral administration and a pupa for oral administration produced by the method are provided. The method is a method of producing a pupa for oral administration, including a step of infecting a larva or pupa of an insect capable of being baculovirus-infected with a recombinant baculovirus having DNA encoding an antigen protein introduced therein and freeze-drying a pupa having pupated from the infected larva or the infected pupa.

IPC Classes  ?

5.

Miscellaneous Design

      
Application Number 1772864
Status Registered
Filing Date 2023-12-08
Registration Date 2023-12-08
Owner KAICO LTD. (Japan)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; soaps; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated toiletry preparations. Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations.

6.

KAICO

      
Application Number 1772899
Status Registered
Filing Date 2023-12-08
Registration Date 2023-12-08
Owner KAICO LTD. (Japan)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; non-medicated cosmetics; non-medicated dentifrices. Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations. Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems. Medical analysis for the diagnosis and treatment of persons; advisory services relating to health; provision of health information; medical examination services; health assessment services; medical consultations; medical information; medical examination services for antibody testing.

7.

KAICO LTD.

      
Application Number 1771574
Status Registered
Filing Date 2023-12-08
Registration Date 2023-12-08
Owner KAICO LTD. (Japan)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; soaps; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated toiletry preparations. Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations. Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems. Medical analysis for the diagnosis and treatment of persons; advisory services relating to health; provision of health information; medical examination services; health assessment services; medical consultations; medical information; medical examination services for antibody testing.

8.

STYLIZED LEAF DESIGN

      
Application Number 230686900
Status Pending
Filing Date 2023-12-08
Owner KAICO LTD. (Japan)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; non medicated body, face, hand, bath, and cosmetic soaps; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated dentifrices. (2) Pharmaceutical preparations, namely, preparations for enhancing immune response to viral, bacterial, and fungal infections; preparations for the prevention of infections caused by viruses, bacteria, and fungi; preparations for the prevention of diseases caused by viruses, bacteria, and fungi; human vaccines for the prevention of norovirus infection; veterinary preparations for the prevention of Porcine Circovirus-associated disease in swine; protein supplements for immune system support and general health and well-being; protein and amino acid preparations, namely, protein dietary supplements and amino acid supplements for use in supporting muscle recovery, enhancing physical performance, and maintaining general health and wellbeing; Medicines for human purposes, namely, preparations for enhancing immune response to viral, bacterial and fungal infections, for the prevention of infections and diseases caused by viruses, bacteria and fungi, and for general health and well-being; medicines for veterinary purposes, namely, preparations for enhancing immune response and for the prevention of infections and diseases caused by viruses, bacteria and fungi, and for general health and well-being in animals; human vaccine preparations; veterinary vaccines; chemical reagents for medical and veterinary purposes, namely, diagnostic reagents for detecting viral, bacterial, and fungal infections in humans and animals; reagents for medical use, namely, diagnostic reagents for the detection of viral, bacterial, and fungal infections in humans; dietary supplements for humans, namely, protein supplements for immune system support and general health and well-being; dietary supplements for humans, namely, dietary supplements containing Cordyceps militaris for immune system support and general health and well-being; dietetic beverages adapted for medical purposes, namely, nutritional beverages for supporting immune function and maintaining general health and well-being; dietetic foods adapted for medical purposes, namely, nutritional food supplements for supporting immune function and maintaining general health and well-being; beverages for babies, namely, nutritional beverages and dietary supplements in liquid form for promoting infant growth and development; food for babies, namely, nutritional cereals and purees for supporting infant growth and development; dietary supplements for animals, namely, protein feed supplements for animals to support immune system function and overall health; dietary supplements for animals, namely, feed supplements for animals containing Cordyceps militaris to support immune system function and overall health; nutritional additives to foodstuffs for animals, for medical purposes, namely, silkworm-based protein additives for animal feed to support immune function, prevent disease, and for overall health; dietetic animal foodstuffs for medical purposes, namely, feed additives for animals to promote immune function, support resistance to viral, bacterial and fungi infections, and for overall health; dietary supplements for animal, namely, protein supplements for animals to promote immune function, support resistance to viral, bacterial and fungi infections, and for overall health; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations, namely, medicated skin cleansers and shampoos.

9.

Miscellaneous Design

      
Serial Number 79388001
Status Registered
Filing Date 2023-12-08
Registration Date 2025-01-28
Owner KAICO LTD. (Japan)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; bath soaps, non-medicated hand soap, perfumed soap, bar soap; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated toiletry preparations Pharmaceutical preparations for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi; vaccines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi; protein and amino acid preparations for medical purposes; medicines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for human purposes; medicines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; animal feed additive for use as a nutritional supplement for medical purposes; dietetic animal foodstuffs for medical purposes; animal fodder additives in the nature of fodder proteins, including those derived from silkworms, for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for medical purposes; protein supplements for animals; medicated toiletry preparations

10.

KAICO

      
Serial Number 79388010
Status Pending
Filing Date 2023-12-08
Owner KAICO LTD. (Japan)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; non-medicated cosmetics; non-medicated dentifrices; all utilizing proteins derived from silkworms Pharmaceutical preparations for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi; vaccines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi; protein and amino acid preparations for medical purposes; medicines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for human purposes; medicines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; animal feed additive for use as a nutritional supplement for medical purposes; dietetic animal foodstuffs for medical purposes; animal fodder additives in the nature of fodder proteins, including those derived from silkworms, for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for medical purpose; protein supplements for animals; medicated toiletry preparations; all utilizing proteins derived from silkworms Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems; all related to proteins derived from silkworms Medical analysis for the diagnosis and treatment of persons; advisory services relating to health; provision of health information; medical examination services; health assessment services; medical consultations; medical information; medical examination services for antibody testing; all related to proteins derived from silkworms

11.

KAICO LTD.

      
Application Number 230565600
Status Registered
Filing Date 2023-12-08
Registration Date 2026-09-07
Owner KAICO LTD. (Japan)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Beauty care cosmetics; hand creams; cosmetics for animals; non-medicated body soaps; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated dentifrices. (2) Pharmaceutical preparations, namely, preparations for enhancing immune response to viral, bacterial, and fungal infections; preparations for the prevention of infections caused by viruses, bacteria, and fungi; preparations for the prevention of diseases caused by viruses, bacteria, and fungi; human vaccines for the prevention of norovirus infection; veterinary preparations for the prevention of Porcine Circovirus-associated disease in swine; protein supplements for immune system support and general health and well-being; protein and amino acid preparations, namely, protein dietary supplements and amino acid supplements for use in supporting muscle recovery, enhancing physical performance, and maintaining general health and wellbeing; Medicines for human purposes, namely, preparations for enhancing immune response to viral, bacterial and fungal infections, for the prevention of infections and diseases caused by viruses, bacteria and fungi, and for general health and well-being; medicines for veterinary purposes, namely, preparations for enhancing immune response and for the prevention of infections and diseases caused by viruses, bacteria and fungi, and for general health and well-being in animals; human vaccine preparations; veterinary vaccines; chemical reagents for medical and veterinary purposes, namely, diagnostic reagents for detecting viral, bacterial, and fungal infections in humans and animals; reagents for medical use, namely, diagnostic reagents for the detection of viral, bacterial, and fungal infections in humans; dietary supplements for humans, namely, protein supplements for immune system support and general health and well-being; dietary supplements for humans, namely, dietary supplements containing Cordyceps militaris for immune system support and general health and well-being; dietetic beverages adapted for medical purposes, namely, nutritional beverages for supporting immune function and maintaining general health and well-being; dietetic foods adapted for medical purposes, namely, nutritional food supplements for supporting immune function and maintaining general health and well-being; beverages for babies, namely, nutritional beverages and dietary supplements in liquid form for promoting infant growth and development; food for babies, namely, nutritional cereals and purees for supporting infant growth and development; dietary supplements for animals, namely, protein feed supplements for animals to support immune system function and overall health; dietary supplements for animals, namely, feed supplements for animals containing Cordyceps militaris to support immune system function and overall health; nutritional additives to foodstuffs for animals, for medical purposes, namely, silkworm-based protein additives for animal feed to support immune function, prevent disease, and for overall health; dietetic animal foodstuffs for medical purposes, namely, feed additives for animals to promote immune function, support resistance to viral, bacterial and fungi infections, and for overall health; dietary supplements for animal, namely, protein supplements for animals to promote immune function, support resistance to viral, bacterial and fungi infections, and for overall health; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations , namely, medicated skin cleansers and shampoos. (1) Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems. (2) Diagnostic services, namely, analysis of biological samples for the diagnosis and treatment of viral, bacterial and fungal infections in humans; advisory services relating to health, namely, providing health information and guidance in the field of immune system support and the prevention of viral, bacterial and fungal infections; provision of health information in the field of immune system support and the prevention of viral, bacterial and fungal infections; medical examination services; health assessment services, namely, assessment of immune function and risk of viral, bacterial and fungal infections for preventative health care purposes; medical consultations in the field of immune system support and the prevention and management of viral, bacterial and fungal infections; medical information in the field of immune health and the prevention and treatment of viral, bacterial and fungal infections; medical examination services for antibody testing.

12.

KAICO

      
Application Number 230686800
Status Registered
Filing Date 2023-12-08
Registration Date 2026-04-08
Owner KAICO LTD. (Japan)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; non-medicated cosmetics; non-medicated dentifrices. (2) Pharmaceutical preparations, namely, preparations for enhancing immune response to viral, bacterial, and fungal infections; preparations for the prevention of infections caused by viruses, bacteria, and fungi; preparations for the prevention of diseases caused by viruses, bacteria, and fungi; human vaccines for the prevention of norovirus infection; veterinary preparations for the prevention of Porcine Circovirus-associated disease in swine; protein supplements for immune system support and general health and well-being; protein and amino acid preparations, namely, protein dietary supplements and amino acid supplements for use in supporting muscle recovery, enhancing physical performance, and maintaining general health and well-being; Medicines for human purposes, namely, preparations for enhancing immune response to viral, bacterial and fungal infections, for the prevention of infections and diseases caused by viruses, bacteria and fungi, and for general health and well-being; medicines for veterinary purposes, namely, preparations for enhancing immune response and for the prevention of infections and diseases caused by viruses, bacteria and fungi, and for general health and well-being in animals; human vaccine preparations; veterinary vaccines; chemical reagents for medical and veterinary purposes, namely, diagnostic reagents for detecting viral, bacterial, and fungal infections in humans and animals; reagents for medical use, namely, diagnostic reagents for the detection of viral, bacterial, and fungal infections in humans; dietary supplements for humans, namely, protein supplements for immune system support and general health and well-being; dietary supplements for humans, namely, dietary supplements containing Cordyceps militaris for immune system support and general health and well-being; dietetic beverages adapted for medical purposes, namely, nutritional beverages for supporting immune function and maintaining general health and well-being; dietetic foods adapted for medical purposes, namely, nutritional food supplements for supporting immune function and maintaining general health and well-being; beverages for babies, namely, nutritional beverages and dietary supplements in liquid form for promoting infant growth and development; food for babies, namely, nutritional cereals and purees for supporting infant growth and development; dietary supplements for animals, namely, protein feed supplements for animals to support immune system function and overall health; dietary supplements for animals, namely, feed supplements for animals containing Cordyceps militaris to support immune system function and overall health; nutritional additives to foodstuffs for animals, for medical purposes, namely, silkworm-based protein additives for animal feed to support immune function, prevent disease, and for overall health; dietetic animal foodstuffs for medical purposes, namely, feed additives for animals to promote immune function, support resistance to viral, bacterial and fungi infections, and for overall health; dietary supplements for animal, namely, protein supplements for animals to promote immune function, support resistance to viral, bacterial and fungi infections, and for overall health; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations , namely, medicated skin cleansers and shampoos. (1) Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems. (2) Diagnostic services, namely, analysis of biological samples for the diagnosis and treatment of viral, bacterial and fungal infections in humans; advisory services relating to health, namely, providing health information and guidance in the field of immune system support and the prevention of viral, bacterial and fungal infections; provision of health information in the field of immune system support and the prevention of viral, bacterial and fungal infections; medical examination services; health assessment services, namely, assessment of immune function and risk of viral, bacterial and fungal infections for preventative health care purposes; medical consultations in the field of immune system support and the prevention and management of viral, bacterial and fungal infections; medical information in the field of immune health and the prevention and treatment of viral, bacterial and fungal infections; medical examination services for antibody testing.

13.

ORAL VACCINE COMPOSITION

      
Application Number JP2023020590
Publication Number 2023/234407
Status In Force
Filing Date 2023-06-02
Publication Date 2023-12-07
Owner
  • KAICO LTD. (Japan)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japan)
Inventor
  • Yamato Kenta
  • Taniguchi Masahiro
  • Nakatake Hirokazu
  • Esaki Keiichi
  • Kusakabe Takahiro

Abstract

An oral vaccine composition against a porcine circovirus-related disease, the oral vaccine composition comprising a pupa or a cell of a baculovirus infectious insect that has been subjected to an infection treatment with a recombinant baculovirus into which a DNA encoding a porcine circovirus type 2 protein has been introduced and subjected to a freeze-drying treatment.

IPC Classes  ?

  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • A61P 11/00 - Drugs for disorders of the respiratory system
  • A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
  • A61P 31/20 - Antivirals for DNA viruses
  • A61P 37/04 - Immunostimulants
  • A61P 17/00 - Drugs for dermatological disorders
  • A61K 9/19 - Particulate form, e.g. powders lyophilised
  • C12N 7/01 - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material
  • C12N 15/34 - Proteins from DNA viruses
  • C12N 15/86 - Viral vectors
  • C12N 15/866 - Baculoviral vectors
  • A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
  • A61K 35/64 - Insects, e.g. bees, wasps or fleas

14.

ORAL VACCINE COMPOSITION

      
Application Number JP2022017328
Publication Number 2022/215742
Status In Force
Filing Date 2022-04-08
Publication Date 2022-10-13
Owner
  • KAICO LTD. (Japan)
  • KAGOSHIMA UNIVERSITY (Japan)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japan)
Inventor
  • Yamato Kenta
  • Miyata Takeshi
  • Kusakabe Takahiro
  • Lee Jae Man
  • Masuda Akitsu

Abstract

[Problem] To provide: a method for simply producing an immunogenic chrysalis for oral administration; and a chrysalis which is for oral administration and produced by said method. [Solution] This method for producing a chrysalis for oral use comprises a step for infecting a larva or chrysalis of a baculovirus infectious insect with a recombinant baculovirus, into which DNA encoding an antigen protein has been introduced, and freeze-drying a chrysalis pupated from the infected larva or the infected chrysalis.

IPC Classes  ?

  • A01K 67/033 - Rearing or breeding invertebrates; New breeds of invertebrates
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/12 - Viral antigens
  • A61P 37/04 - Immunostimulants
  • C12N 5/10 - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells
  • C12N 15/34 - Proteins from DNA viruses
  • C12N 15/40 - Proteins from RNA viruses, e.g. flaviviruses
  • C12N 15/866 - Baculoviral vectors

15.

ORAL VACCINE COMPOSITION

      
Document Number 03216205
Status Pending
Filing Date 2022-04-08
Open to Public Date 2022-10-13
Owner
  • KAICO LTD. (Japan)
  • KAGOSHIMA UNIVERSITY (Japan)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japan)
Inventor
  • Yamato, Kenta
  • Miyata, Takeshi
  • Kusakabe, Takahiro
  • Lee, Jae Man
  • Masuda, Akitsu

Abstract

[Problem] To provide: a method for simply producing an immunogenic chrysalis for oral administration; and a chrysalis which is for oral administration and produced by said method. [Solution] This method for producing a chrysalis for oral use comprises a step for infecting a larva or chrysalis of a baculovirus infectious insect with a recombinant baculovirus, into which DNA encoding an antigen protein has been introduced, and freeze-drying a chrysalis pupated from the infected larva or the infected chrysalis.

IPC Classes  ?

  • A01K 67/30 - Rearing or breeding invertebrates
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
  • A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/12 - Viral antigens
  • A61P 37/04 - Immunostimulants
  • C12N 5/10 - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells
  • C12N 15/34 - Proteins from DNA viruses
  • C12N 15/40 - Proteins from RNA viruses, e.g. flaviviruses
  • C12N 15/866 - Baculoviral vectors

16.

BABESIA PROTOZOA, AND DIAGNOSTIC METHOD FOR BABESIOSIS

      
Application Number JP2019008255
Publication Number 2020/174690
Status In Force
Filing Date 2019-02-25
Publication Date 2020-09-03
Owner KAICO LTD. (Japan)
Inventor
  • Kusakabe, Takahiro
  • Arakawa, Takeshi
  • Tamaki, Yukihiro
  • Tsuji, Naotoshi

Abstract

BabesiaBabesia protozoa, the amino acid sequence of the N-terminal signal peptide thereof and the amino acid sequence of the region from a transmembrane region to the C-terminus thereof; and a detection or diagnostic method for Babesiosis using the protein.

IPC Classes  ?

  • C07K 14/44 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from protozoa
  • A61K 39/018 - Babesia antigens, e.g. Theileria antigens
  • A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
  • C12N 5/07 - Animal cells or tissues
  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
  • G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor